Sub: Outcome of the Board Meeting

In continuation to Company’s intimation of Board meeting filed with BSE and NSE on 7th May, 2026, we wish to inform you that the Board meeting held today i.e., 13th May, 2026, the Board inter-alia considered and approved the following:

Audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March, 2026 as recommended by the Audit committee at its meeting held earlier in the day enclosed herewith the Financial Results as approved by the Board along with the report of the Statutory Auditors including the declaration on Unmodified Opinion.
Recommended to the Shareholders for their approval in the ensuing Annual General Meeting a payment of Rs. 1.25/- per share as Final Dividend.
Reappointment of M/s. Madhavan, Mohan & Associates, Cost Accountants, as the cost auditor of the company for the financial year 2026-2027 as recommended by the members of the Audit committee in their meeting held earlier in the day.
Appointment of M/s. Brahmayya & Co, Chartered Accountants as the Internal Auditors of the Company for the Financial Year 2026-2027 as recommended by the members of the Audit committee in their meeting held earlier in the day.

The details required as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III thereof and SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dt.11.11.2024, as amended from time to time is enclosed as Annexure I.

The said Meeting commenced at 2:00 P.M. and concluded at 7:00 P.M.

Kindly take the above on record.

Thanking You,

Yours faithfully,

For CHEMFAB ALKALIS LIMITED

BHARATRAJ

PANCHAL

Bharatraj Panchal

Company Secretary

FCS: 9828

CHEMFAB ALKALIS LIMITED

ANAB

Certificate No. 0165-80228 / 296571566

An OHSAS 18001 and ISO 14001 Certified Company

CIN No.: L24290TN2009PLC071563

Member - Dr. Rao's Group of Companies

Regd. Off: "TEAM House", GST Road, Vandalur, Chennai - 600 048, India

Plant: "Gharananda Place", Kalapet, Puducherry - 605 014, India Ph: +91 413 2655111,

E-mail: [email protected], www.chemfabalkalis.com

Responsible Care®

CCAL

CHEMFAB ALKALIS LIMITED

Annexure-1

Details of the Auditors

[Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements Regulations, 2015 and SEBI Master Circular no. SEBI/HO/CFD/PoD2/CIR/P/0155 dt.11.11.2024]

S. No.	Type of Auditors	Internal Auditors	Cost Auditors
1	Name	M/s. Brahmayya & Co, Chartered Accountants	M/s. Madhavan, Mohan & Associates, Cost Accountants
2	Reason for Change viz, appointment, resignation, removal, death or otherwise	Appointment	Appointment
3	Date of appointment and terms of appointment	For a period of one year from 01.04.2026 to 31.03.2027	For a period of one year from 01.04.2026 to 31.03.2027
4	Brief Profile	Brahmayya & Co., founded in 1932 by Mr. Parvataneni Brahmayya, is one of the pioneering Chartered Accountancy firms in India. With over 80 years of legacy, the firm is committed to delivering high standard professional services while upholding the ethics and code of conduct of the profession. Guided by these core principles, Brahmayya & Co. continues to grow and exceed	M/s. Madhavan, Mohan & Associates, Cost Accountants, (Firm No. 3483) is a firm of Cost Accountants based in Chennai.
5	Relationship between Directors inter-se	There is no association with any of the Directors.	There is no association with any of the Directors.

CHEMFAB

ANAB

ASSOCIATION

Chartered Accountants

Certificate No. 0142-82238 / 2005 T1544

All GP/CoG / BDO and ISO 14001 Certified Company

CIN No.: L24290TN2009PLC071563

Member - Dr. Rao's Group of Companies

Regd. Off: "TEAM House", GST Road, Vandalur, Chennai - 600 048, India

Plant: "Gharananda Plaza", Kalapat, Puducherry - 605 014, India Ph: +91 413 2655111,

E-mail: [email protected], www.chemfabalkalis.com

Responsible Care®

CCAL

REF: CHEMFAB/SEC/2026-27

13th May, 2026

BSE Limited

Corporate Relationship Department

Phiroze Jeejeebhoy Towers,

Dalal Street,

Mumbai- 400 001.

BSE – Scrip Code: 541269

National Stock Exchange of India Limited

The Manager, Listing Department

“Exchange Plaza”

Bandra - Kurla Complex, Bandra (E)

Mumbai - 400 051

NSE Symbol: CHEMFAB

Dear Sir/Madam,

Sub: Declaration with respect to the Audit Report with unmodified opinion to the Audited Financial Results for the Financial Year ended 31st March 2026

We hereby declare that the Audit report issued by our Statutory Auditor M/s Deloitte Haskin & Sells LLP on the Audited financial results of the Company for the Financial Year ended 31st March 2026 is unmodified.

The above declaration is made pursuant to the Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

Thanking You,

Yours faithfully,

For CHEMFAB ALKALIS LIMITED

Regn. No. OHS 66228

OHSAS 18001 and 14001

Regd. off: 'TEAM HOUSE', G.S.T. Road, Vandalur, Chennai - 600 048, India

Chennai office : No.1A, Jeyamkondar Towers, 12/40 Murrays Gate Road, Alwarpet, Chennai - 600 018.

Tel: +91 44 42031444 E-mail: [email protected], Website: www.chemfabalkalis.com

Plant: "Gnanananda Place", Kalapet, Puducherry - 605 014, India. Phone: +91 413 2261000

OUR COMBSTEMENT TO SUSTAINABILITY

Deloitte Haskins & Sells LLP

Chartered Accountants
ASV N Ramana Tower,
52, Venkatnarayana Road
T. Nagar
Chennai – 600 017
Tamil Nadu, India
Tel: +91 44 6688 5000
Fax: +91 44 6688 5050

INDEPENDENT AUDITOR'S REPORT ON AUDIT OF ANNUAL STANDALONE FINANCIAL RESULTS AND REVIEW OF QUARTERLY FINANCIAL RESULTS

TO THE BOARD OF DIRECTORS OF CHEMFAB ALKALIS LIMITED

Opinion and Conclusion

We have (a) audited the Standalone Financial Results for the year ended March 31, 2026 and (b) reviewed the Standalone Financial Results for the quarter ended March 31, 2026 (refer ‘Other Matters’ section below), which were subject to limited review by us, both included in the accompanying “Statement of Standalone Financial Results for the Quarter and Year Ended March 31, 2026.” of CHEMFAB ALKALIS LIMITED (the “Company”), being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “LODR Regulations”).

(a) Opinion on Annual Standalone Financial Results

In our opinion and to the best of our information and according to the explanations given to us, the Standalone Financial Results for the year ended March 31, 2026:

i. are presented in accordance with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended; and

ii. gives a true and fair view in conformity with the recognition and measurement principles laid down in the Indian Accounting Standards and other accounting principles generally accepted in India of the net profit and other comprehensive income and other financial information of the Company for the year then ended.

(b) Conclusion on Unaudited Standalone Financial Results for the quarter ended March 31, 2026

With respect to the Standalone Financial Results for the quarter ended March 31, 2026, based on our review conducted as stated in paragraph (b) of Auditor’s Responsibilities section below, nothing has come to our attention that causes us to believe that the Standalone Financial Results for the quarter ended March 31, 2026, prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement.

Regd. Office: One International Center, Tower 3, 31st floor, Senapati Bapat Marg, Elphinstone Road (West), Mumbai-400 013, Maharashtra, India. Deloitte Haskins & Sells LLP is registered with Limited Liability having LLP identification No: AAB-8737

Deloitte Haskins & Sells LLP

Basis for Opinion on the Audited Standalone Financial Results for the year ended March 31, 2026

We conducted our audit in accordance with the Standards on Auditing ("SA"s) specified under Section 143(10) of the Companies Act, 2013 (the "Act"). Our responsibilities under those Standards are further described in paragraph (a) of Auditor's Responsibilities section below. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India (the "ICAI") together with the ethical requirements that are relevant to our audit of the Standalone Financial Results for the year ended March 31, 2026 under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the ICAI's Code of Ethics. We believe that the audit evidence obtained by us is sufficient and appropriate to provide a basis for our audit opinion.

Management's and Board of Directors' Responsibilities for the Statement

This Statement which includes the Standalone Financial Results is the responsibility of the Company's Board of Directors and has been approved by them for the issuance. The Standalone Financial Results for the year ended March 31, 2026 has been compiled from the related audited standalone financial statements. This responsibility includes the preparation and presentation of the Standalone Financial Results for the quarter and year ended March 31, 2026 that give a true and fair view of the net profit and other comprehensive income and other financial information in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the LODR Regulations. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the Standalone Financial Results that give a true and fair view and is free from material misstatement, whether due to fraud or error.

In preparing the Standalone Financial Results, the Board of Directors is responsible for assessing the Company's ability, to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

The Board of Directors is also responsible for overseeing the financial reporting process of the Company.

Auditor's Responsibilities

(a) Audit of the Standalone Financial Results for the year ended March 31, 2026

Our objectives are to obtain reasonable assurance about whether the Standalone Financial Results for the year ended March 26, 2026 as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of this Standalone Financial Results.

Deloitte Haskins & Sells LLP

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

Identify and assess the risks of material misstatement of the Annual Standalone Financial Results, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates made by the Board of Directors.
Evaluate the appropriateness and reasonableness of disclosures made by the Board of Directors in terms of the requirements specified under Regulation 33 of the LODR Regulations.
Conclude on the appropriateness of the Board of Directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the Company to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the Statement or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.
Evaluate the overall presentation, structure and content of the Annual Standalone Financial Results, including the disclosures, and whether the Annual Standalone Financial Results represent the underlying transactions and events in a manner that achieves fair presentation.
Obtain sufficient appropriate audit evidence regarding the Annual Standalone Financial Results of the Company to express an opinion on the Annual Standalone Financial Results.

Materiality is the magnitude of misstatements in the Annual Standalone Financial Results that, individually or in aggregate, makes it probable that the economic decisions of a reasonably knowledgeable user of the Annual Standalone Financial Results may be influenced. We consider quantitative materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to evaluate the effect of any identified misstatements in the Annual Standalone Financial Results.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings including any significant deficiencies in internal control that we identify during our audit.

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

(b) Review of the Standalone Financial Results for the quarter ended March 31, 2026

We conducted our review of the Standalone Financial Results for the quarter ended March 31, 2026 in accordance with the Standard on Review Engagements ("SRE") 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity', issued by the ICAI. A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with SAs specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Other Matters

The Statement includes the results for the Quarter ended March 31, 2026 being the balancing figure between audited figures in respect of the full financial year and the published year to date figures up to the third quarter of the current financial year which were subject to limited review by us. Our report on the Statement is not modified in respect of this matter.

For Deloitte Haskins & Sells LLP
Chartered Accountants
(Firm's Registration No. 117366W/W-100018)

P Usha Parvathy
Digitally signed by P
Usha Parvathy
Date: 2026.05.13
18:19:00 +05'30'
P Usha Parvathy
Partner
Membership No. 207704
UDIN: 26207704CFTURW8906

Place: Chennai
Date: 13 May 2026

| Chemfab Alkalis Limited
CIN:L24290TN:2009PLC071563
Regd. Office: Team House, Vandalur, Chennai 600 048.
Phone No: +91 44 66799595 Fax No: +91 44 66799561 | | | | | | |
| --- | --- | --- | --- | --- | --- | --- |
| (Amount Rs. In Lakhs)
STATEMENT OF STANDALONE FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED 31/03/2026 | | | | | | |
| Sl. No. | Particulars | 3 Months ended 31/03/2026
(Refer Note 7) | Preceding 3 Months ended 31/12/2025
(Unaudited) | Corresponding 3 months ended 31/03/2025 in the previous year
(Refer Note 7) | Current Year ended 31/03/2026
(Audited) | Previous year ended 31/03/2025
(Audited) |
| 1 | Income
(a) Revenue from Operations
(b) Other Income
Total Income | 6,872.61
401.03 | 6,185.38
185.94 | 8,784.59
127.42 | 28,856.60
827.45 | 32,209.05
584.92 |
| 2 | Expenses
(a) Cost of Materials Consumed
(b) Purchase of Stock in trade
(c) Changes in Inventories of Finished goods and Work-in -Progress
(d) Direct Manufacturing Expenses - Power, Fuel & Others
(e) Employee Benefits Expense
(f) Finance Cost
(g) Depreciation and Amortisation Expense
(h) Other Expenses
Total Expenses | 7,273.64
1,683.39
268.40
(72.50)
2,867.35
581.65
208.41
700.06
807.07 | 6,371.32
1,346.12
-
172.17
2,673.10
613.95
197.29
644.29
862.73 | 8,912.01
2,248.64
-
171.40
3,062.45
571.99
156.20
964.17
1,161.83 | 2,684.05
7,463.57
268.40
264.32
11,075.33
2,446.56
754.01
2,442.46
3,897.22 | 8,492.07
735.23
(674.65)
11,716.54
2,289.71
491.58
3,238.79
4,321.48 |
| 3 | Profit before Tax (1-2) | 229.81 | (138.33) | 575.33 | 1,072.18 | 2,183.22 |
| 4 | Tax Expense
- Current tax
- Deferred tax
Total Tax Expense | 35.62
38.42
74.04 | (18.19)
(16.34)
(34.53) | 100.72
81.55
182.27 | 193.06
128.53
321.59 | 375.41
285.39
660.80 |
| 5 | Net Profit / (Loss) after Tax (3-4) | 155.77 | (103.80) | 393.06 | 750.59 | 1,522.42 |
| 6 | Other Comprehensive Income
(a) Items that will not be reclassified to the Statement of Profit and Loss
- Remeasurement of net defined benefit liability
- Fair value gain on investments in equity instruments designated as at FVTOCI
- Income tax relating to items that will not be reclassified to profit or loss
(b) Items that will be reclassified to the Statement of Profit and Loss
Total Other Comprehensive Income / (Loss) Net of Tax | 42.64
(2.04)
(12.42)
- | 14.52
(1.44)
(4.23)
- | 40.95
(5.55)
(11.93)
- | 86.21
(2.02)
(25.11)
- | 58.09
(2.75)
(16.91)
- |
| 7 | Total Comprehensive Income / (Loss) (5+6) | 183.95 | (94.95) | 416.53 | 809.67 | 1,560.85 |
| 8 | Paid-up Equity Share Capital (Face Value of Rs. 10 per share) (Refer note 3) | 1,437.37 | 1,437.37 | 1,436.37 | 1,437.37 | 1,436.37 |
| 9 | Reserves (Other Equity) | | | | 39,975.52 | 39,341.40 |
| 10 | Earning per Share
(Face Value of Rs. 10 per share)
(a) Basic
(b) Diluted | (not annualised)
1.08
1.08 | (not annualised)
(0.72)
(0.72) | (not annualised)
2.74
2.73 | 5.22
5.22 | 10.65
10.61 |

Chemfab Alkalis Limited

CIN:L24290TN2009PLC071563
Regd. Office: Team House, Vandalur, Chennai 600 048.
Phone No: +91 44 66799595 Fax No: +91 44 66799561

NOTES:

The above Statement of Standalone financial results were reviewed and recommended by the Audit Committee at its meeting held on 13 May 2026 and approved by the Board of Directors of the Company at their meeting held on that date.
The Company has identified its reportable segments in accordance with Ind AS 108 - Operating Segments. Accordingly, two reportable segments i.e. Chemicals and Related Products and PVC - O Pipes have been identified, the details of which are given below:

(Amount Rs. In Lakhs)

| Sl. No. | Particulars | 3 Months ended 31/03/2026
(Refer Note 7) | Preceding 3 Months ended 31/12/2025
(Unaudited) | Corresponding 3 months ended 31/03/2025 in the previous year
(Refer Note 7) | Current Year ended 31/03/2026
(Audited) | Previous year ended 31/03/2025
(Audited) |
| --- | --- | --- | --- | --- | --- | --- |
| I | Segment Revenue | | | | | |
| a) Chemicals and related Products | 5,563.23 | 4,751.80 | 5,631.13 | 19,568.84 | 19,064.00 |
| b) PVC-O Pipes | 1,311.24 | 1,464.95 | 3,153.46 | 9,346.75 | 13,145.05 |
| Less: Inter Segment Revenue | 6,874.47 | 6,216.75 | 8,784.59 | 28,915.59 | 32,209.05 |
| | (1.86) | (31.37) | - | (58.99) | - |
| | Net Segment Revenue | 6,872.61 | 6,185.38 | 8,784.59 | 28,856.60 | 32,209.05 |
| II | Segment Result before tax | | | | | |
| a) Chemicals and related Products | 124.27 | (193.60) | 287.24 | (591.14) | (959.13) |
| b) PVC-O Pipes | (87.08) | 66.62 | 316.87 | 1,589.88 | 3,049.01 |
| Total | 37.19 | (126.98) | 604.11 | 998.74 | 2,089.88 |
| Less: Inter Segment Result | - | - | - | - | - |
| Less: Finance Cost | (208.41) | (197.29) | (156.20) | (754.01) | (491.58) |
| Add: Other Income | 401.03 | 185.94 | 127.42 | 827.45 | 584.92 |
| | Total Profit Before Tax | 229.81 | (138.33) | 575.33 | 1,072.18 | 2,183.22 |
| III | Segment Assets: | | | | | |
| a) Chemicals and related Products | 21,403.23 | 22,098.67 | 19,275.78 | 21,403.23 | 19,275.78 |
| b) PVC-O Pipes | 21,906.91 | 21,120.32 | 15,858.21 | 21,906.91 | 15,858.21 |
| Total Segment Assets | 43,310.14 | 43,218.99 | 35,133.99 | 43,310.14 | 35,133.99 |
| Add: Unallocable assets | 18,113.81 | 17,707.94 | 19,463.71 | 18,113.81 | 19,463.71 |
| | Total Assets | 61,423.95 | 60,926.93 | 54,597.70 | 61,423.95 | 54,597.70 |
| IV | Segment Liabilities: | | | | | |
| a) Chemicals and related Products | 5,356.56 | 6,866.68 | 3,207.72 | 5,356.56 | 3,207.72 |
| b) PVC-O Pipes | 2,194.70 | 1,208.69 | 2,181.34 | 2,194.70 | 2,181.34 |
| Total Segment Liabilities | 7,551.26 | 8,075.37 | 5,389.06 | 7,551.26 | 5,389.06 |
| Add: Unallocable liabilities | 12,459.80 | 11,615.49 | 8,430.87 | 12,459.80 | 8,430.87 |
| | Total Liabilities | 20,011.06 | 19,690.86 | 13,819.93 | 20,011.06 | 13,819.93 |

During the current year ended 31 March 2026, the Company had allotted 10,000 Equity shares of Rs. 10 each upon exercise of Employee stock options by the eligible employees under Employee's Stock Option Scheme "CAESOS 2020".
The Company has estimated and recognized the impact of implementation of the New Labour Codes under Employee benefits expense for the year ended 31 March 2026. The impact of the same is not material to the results for the year.

The Company continues to monitor the issuance and finalisation of State Rules and further clarifications from the Government in respect of other aspects of the Labour Codes. Any additional impact arising from such developments will be assessed and appropriately accounted for in the Standalone Financial Results as and when such rules are notified or clarifications are issued.

The Statement of Standalone Assets and Liabilities as at 31 March 2026 and the Statement of Standalone Cash Flows are provided as annexures to this Statement.
The Board of Directors of the Company has recommended a final dividend of 12.50 % (Rs. 1.25 per Equity Share of Rs. 10 each) for the financial year 2025-26 which is subject to the approval of the shareholders in the forthcoming Annual General Meeting of the Company.
The figures for the quarter ended 31 March 2026 and 31 March 2025 are the balancing figures between audited figures of the full financial year ended 31 March 2026 and published year to date figure upto third quarter ended 31 December 2025 and audited figures of the full financial year ended 31 March 2025 and published year to date figures upto third quarter ended 31 December 2024 respectively.

Place: Chennai
Date: 13 May 2026

For Chemfab Alkalis Limited

Suresh Krishnamurthi Rao
Chairman
DIN No: 00127809

| Chemfab Alkalis Limited
CIN:1.24290TN:2009PLC071563
Regd. Office: Team House, Vandalur, Chennai 600 048.
Phone No: +91 44 66799595 Fax No: +91 44 66799561 | | |
| --- | --- | --- |
| STATEMENT OF STANDALONE ASSETS AND LIABILITIES (Refer Note 5) | | |
| Particulars | (Amount Rs. In Lakhs) | |
| | As at Current Year ended
31/03/2026
Audited | As at Previous Year ended
31/03/2025
Audited |
| I. ASSETS
(1) Non-current assets | | |
| (a) Property Plant and Equipment | 31,658.63 | 24,224.58 |
| (b) Right of Use Assets | 713.56 | 630.66 |
| (c) Capital work-in-progress | 2,838.76 | 1,170.21 |
| (d) Intangible Assets | 58.76 | 3.68 |
| (e) Financial Assets | | |
| (i) Investments | | |
| - Subsidiary | 14,937.00 | 14,932.00 |
| - Others | 7.91 | 9.54 |
| (ii) Other Financial Assets | 207.41 | 184.89 |
| (f) Non Current Tax Assets (Net) | 189.76 | 279.13 |
| (g) Deferred Tax Assets (Net) | 2,144.84 | 2,298.49 |
| (h) Other Non-Current Assets | 423.69 | 3,485.66 |
| Total Non-Current Assets | 53,180.32 | 47,218.84 |
| (2) Current assets | | |
| (a) Inventories | 2,450.05 | 2,309.42 |
| (b) Financial Assets | | |
| (i) Investments | 752.81 | 1,478.56 |
| (ii) Trade Receivables | 2,262.07 | 2,007.12 |
| (iii) Cash and Cash Equivalents | 2.89 | 442.10 |
| (iv) Bank Balances other than (iii) above | 83.58 | 20.21 |
| (v) Other Financial Assets | 28.08 | 55.67 |
| (c) Other Current Assets | 836.63 | 550.08 |
| | 6,416.11 | 6,863.16 |
| Asset Held for Sale | 1,827.52 | 515.70 |
| Total Current Assets | 8,243.63 | 7,378.86 |
| TOTAL ASSETS | 61,423.95 | 54,597.70 |
| I. EQUITY AND LIABILITIES | | |
| (1) Equity | | |
| (a) Equity Share Capital (Refer Note 3) | 1,437.37 | 1,436.37 |
| (b) Other Equity | 39,975.52 | 39,341.40 |
| Total Equity | 41,412.89 | 40,777.77 |
| (2) Non-current liabilities | | |
| (a) Financial Liabilities | | |
| (i) Borrowings | 8,143.00 | 6,379.50 |
| (ii) Lease Liabilities | 234.89 | 141.09 |
| (iii) Other Financial Liabilities | 60.98 | 54.97 |
| (b) Provisions | 306.71 | 268.02 |
| (c) Other Non-Current Liabilities | 46.25 | 120.00 |
| Total Non-Current Liabilities | 8,791.83 | 6,963.58 |
| (3) Current liabilities | | |
| (a) Financial Liabilities | | |
| (i) Borrowings | 4,148.62 | 1,874.00 |
| (ii) Lease Liabilities | 35.08 | 36.17 |
| (iii) Trade Payables | | |
| - Total Outstanding dues of micro enterprises and small enterprises | 58.16 | 79.15 |
| - Total Outstanding dues of creditors other than micro enterprises and small enterprises | 3,049.34 | 3,036.23 |
| (iv) Other Financial Liabilities | 1,492.65 | 250.77 |
| (b) Provisions | 151.95 | 151.48 |
| (c) Current Tax Liabilities (Net) | 102.62 | 109.32 |
| (d) Other Current Liabilities | 2,180.81 | 1,319.23 |
| Total Current Liabilities | 11,219.23 | 6,856.35 |
| Total Liabilities | 20,011.06 | 13,819.93 |
| TOTAL EQUITY AND LIABILITIES | 61,423.95 | 54,597.70 |

Place : Chennai
Date: 13 May 2026

SGS

For Chemfab Alkalis Limited

Suresh Krishnamurthi Rao
Chairman
DIN No: 00127609

| Chemfab Alkalis Limited
CIN:L24290TN2009PLC071563
Regd. Office: Team House, Vandalur, Chennai 600 048.
Phone No: +91 44 66799595 Fax No: +91 44 66799561 | | |
| --- | --- | --- |
| STATEMENT OF STANDALONE CASH FLOWS (Refer Note 5) | | |
| (Amount Rs. In Lakhs) | | |
| Particulars | As at Current Year ended
31/03/2026
(Audited) | As at Previous Year ended
31/03/2025
(Audited) |
| A. Cash flow from Operating Activities | | |
| Profit/(Loss) for the year | 750.59 | 1,522.42 |
| Adjustment for: | | |
| Income Tax Expense | 321.59 | 660.80 |
| Depreciation of property, plant and equipment | 2,442.46 | 3,238.79 |
| Dividend Income | (0.08) | - |
| Gain on redemption of investments | (21.95) | (4.67) |
| Equity settled share-based payment expense | - | 11.16 |
| Interest Income on fixed deposits with banks | (3.67) | (11.31) |
| Interest Income on Income Tax Refund | (14.84) | - |
| Finance Costs | 754.01 | 491.58 |
| Gain on disposal of property, plant and equipment | (256.34) | (63.92) |
| Bad Receivables written off | 39.08 | 76.79 |
| Provision for Expected credit loss (Net) | (40.03) | (71.35) |
| Liabilities no longer required written back | (97.66) | (163.69) |
| Unrealised Exchange Variation (Net) | 10.97 | (8.61) |
| Operating cash flows before movements in working capital | 3,884.13 | 5,677.99 |
| (Increase) / Decrease in Trade Receivables | (253.32) | 109.46 |
| (Increase) / Decrease in Other Non Current and Current Financial assets
and Non current and Current assets | (299.82) | 853.65 |
| (Increase) / Decrease in Inventories | (140.63) | (766.35) |
| Increase / (Decrease) in Trade Payables Other Current liabilities and Non-Current
Liabilities and Provisions | 999.57 | 834.53 |
| Changes in Working Capital and Other changes | 305.80 | 1,031.29 |
| Cash generated by operations | 4,189.93 | 6,709.28 |
| Income Taxes (Paid) / Refund and Interest Income Received | (95.55) | (617.49) |
| Net cash from Operating Activities (A) | 4,094.38 | 6,091.79 |
| B. Cash flow from Investing Activities | | |
| Purchase of Property, Plant and Equipment | (9,789.11) | (8,878.63) |
| Proceeds from Sale of Property, Plant and Equipment and Assets Held for Sale | 1,484.56 | 67.76 |
| Net movement in Bank balances not considered as Cash and cash equivalents | (43.61) | 2,364.74 |
| Dividend Received from Non-current and Current Investments | 0.08 | - |
| Interest Income | 23.13 | 130.00 |
| Investment in Equity Shares of Subsidiary Company | (5.00) | - |
| Investment in Preference Shares of Subsidiary Company | - | (4,400.00) |
| Net Cash from/(used in) Investing Activities (B) | (8,329.95) | (10,716.13) |
| C. Cash flow from Financing Activities | | |
| Dividend Paid, including movement from unpaid dividend account | (179.92) | (173.19) |
| Issue of Equity Shares | 9.78 | 104.10 |
| Payment of lease liabilities | (41.24) | (27.97) |
| Borrowings taken/(repaid) (net) | 1,100.00 | - |
| Proceeds from Term Loan taken | 2,550.00 | 6,880.00 |
| Finance Cost on Lease Liabilities | (21.22) | (15.89) |
| Repayment of Term Loan made during the year | (1,674.00) | (646.50) |
| Short term Borrowings (repaid)/taken (net) | 2,062.12 | 200.00 |
| Finance Costs paid on Borrowings | (734.91) | (440.14) |
| Net Cash from/(used in) Financing Activities (C) | 3,070.61 | 5,880.41 |
| D. Net (Decrease)/Increase in Cash and Cash Equivalents (A) + (B) + (C) | (1,164.96) | 1,256.07 |
| E. Cash and Cash Equivalents (Opening) | 1,920.66 | 664.59 |
| F. Cash and Cash Equivalents (Closing) | 755.70 | 1,920.66 |
| Notes:
(i) Reconciliation of Cash and cash equivalents
Cash and Cash Equivalents as per Balance Sheet
(as defined in INDAS 7 Cash Flow Statements)
Cash and cash equivalents at the end of the Year | 2.89
752.81
755.70 | 442.10
1,478.56
1,920.66 |

Place : Chennai
Date: 13 May 2026

RESEARCH & DEVELOPMENT
CHENNAI

For Chemfab Alkalis Limited
Suresh Krishnamurthi Rao
Chairman
DIN No: 00127809

Deloitte Haskins & Sells LLP

Chartered Accountants
ASV N Ramana Tower,
52, Venkatnarayana Road
T. Nagar
Chennai – 600 017
Tamil Nadu, India
Tel: +91 44 6688 5000
Fax: +91 44 6688 5050

INDEPENDENT AUDITOR'S REPORT ON AUDIT OF ANNUAL CONSOLIDATED FINANCIAL RESULTS AND REVIEW OF QUARTERLY FINANCIAL RESULTS

TO THE BOARD OF DIRECTORS OF CHEMFAB ALKALIS LIMITED

Opinion and Conclusion

We have (a) audited the Consolidated Financial Results for the year ended March 31, 2026 and (b) reviewed the Consolidated Financial Results for the quarter ended March 31, 2026 (refer 'Other Matters' section below), which were subject to limited review by us, both included in the accompanying Statement of Consolidated Financial Results for the Quarter and Year Ended March 31, 2025. of CHEMFAB ALKALIS LIMITED (the "Holding Company") and its subsidiaries (the Holding Company and its subsidiaries together referred to as the "Group"), being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the "LODR Regulations").

(a) Opinion on Annual Consolidated Financial Results

In our opinion and to the best of our information and according to the explanations given to us, and based on the consideration of the audit reports of the other auditors on separate financial statements of subsidiaries referred to in Other Matters section below, the Consolidated Financial Results for the year ended March 31, 2026:

(i) includes the financial results of the following entities:

Name of the entity	Relationship
Chemfab Alkalis Limited	Parent Company
Chemfab Karaiikal Limited (Previously Chemfab Alkalis Karaikal Limited)	Subsidiary Company
Chemfab Hiitech Piping Limited (Incorporated on 28 October 2025)	Subsidiary Company

(ii) are presented in accordance with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended; and

(iii) gives a true and fair view in conformity with the recognition and measurement principles laid down in the Indian Accounting Standards and other accounting principles generally accepted in India of the consolidated net loss and consolidated other comprehensive loss (net) and other financial information of the Group for the year ended March 31, 2026.

(b) Conclusion on Unaudited Consolidated Financial Results for the quarter ended March 31, 2026

With respect to the Consolidated Financial Results for the quarter ended March 31, 2026, based on our review conducted and procedures performed as stated in paragraph (b) of Auditor's Responsibilities section below and based on the consideration of the review reports of the other auditors referred to in paragraph (b) of Other Matters section below, nothing has come to our attention that causes us to believe that the Consolidated Financial Results for the quarter ended March 31, 2026, prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement.

Regd. Office: One International Center, Tower 3, 31st floor, Senapati Bapat Marg, Elphinstone Road (West), Mumbai-400 013, Maharashtra, India.

Deloitte Haskins & Sells LLP is registered with Limited Liability having LLP identification No: AAB-8737

Basis for Opinion on the Audited Consolidated Financial Results for the year ended March 31, 2026

We conducted our audit in accordance with the Standards on Auditing ("SA"s) specified under Section 143(10) of the Companies Act, 2013 (the "Act"). Our responsibilities under those Standards are further described in paragraph (a) of Auditor's Responsibilities section below. We are independent of the Group, in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India (the "ICAI") together with the ethical requirements that are relevant to our audit of the Consolidated Financial Results for the year ended March 31, 2026 under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the ICAI's Code of Ethics. We believe that the audit evidence obtained by us and the audit evidence obtained by the other auditors in terms of their reports referred to in Other Matters section below, is sufficient and appropriate to provide a basis for our audit opinion.

Management's and Board of Directors' Responsibilities for the Statement

This Statement, which includes the Consolidated Financial Results is the responsibility of the Holding Company's Board of Directors and has been approved by them for the issuance. The Consolidated Financial Results for the year ended March 31, 2026, has been compiled from the related audited consolidated financial statements. This responsibility includes the preparation and presentation of the Consolidated Financial Results for the quarter and year ended March 31, 2026 that give a true and fair view of the consolidated net loss and consolidated other comprehensive loss (net) and other financial information of the Group in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards, prescribed under Section 133 of the Act, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the LODR Regulations.

The respective Board of Directors of the companies included in the Group are responsible for maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Group and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the respective financial results that give a true and fair view and are free from material misstatement, whether due to fraud or error, which have been used for the purpose of preparation of this Consolidated Financial Results by the Directors of the Holding Company, as aforesaid.

In preparing the Consolidated Financial Results, the respective Board of Directors of the companies included in the Group are responsible for assessing the ability of the respective entities to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the respective Board of Directors either intends to liquidate their respective entities or to cease operations, or has no realistic alternative but to do so.

The respective Board of Directors of the companies included in the Group are responsible for overseeing the financial reporting process of the Group.

Auditor's Responsibilities

(a) Audit of the Consolidated Financial Results for the year ended March 31, 2026

Our objectives are to obtain reasonable assurance about whether the Consolidated Financial Results for the year ended March 31, 2026 as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of this Consolidated Financial Results.

As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

Identify and assess the risks of material misstatement of the Annual Consolidated Financial Results, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of such controls.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates made by the Board of Directors.
Evaluate the appropriateness and reasonableness of disclosures made by the Board of Directors in terms of the requirements specified under Regulation 33 of the LODR Regulations.
Conclude on the appropriateness of the Board of Directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the Group to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the Consolidated Financial Results or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Group to cease to continue as a going concern.
Evaluate the overall presentation, structure and content of the Annual Consolidated Financial Results, including the disclosures, and whether the Annual Consolidated Financial Results represent the underlying transactions and events in a manner that achieves fair presentation.
Perform procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the LODR Regulations to the extent applicable.
Obtain sufficient appropriate audit evidence regarding the Annual Standalone Financial Results of the entities within the Group to express an opinion on the Annual Consolidated Financial Results. We are responsible for the direction, supervision and performance of the audit of financial information of entities included in the Annual Consolidated Financial Results of which we are the independent auditors. For the other entities included in the Annual Consolidated Financial Results, which have been audited by the other auditors, such other auditors remain responsible for the direction, supervision and performance of the audits carried out by them. We remain solely responsible for our audit opinion.

Materiality is the magnitude of misstatements in the Annual Consolidated Financial Results that, individually or in aggregate, makes it probable that the economic decisions of a reasonably knowledgeable user of the Annual Consolidated Financial Results may be influenced. We consider quantitative materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to evaluate the effect of any identified misstatements in the Annual Consolidated Financial Results.

We communicate with those charged with governance of the Holding Company and such other entities included in the Consolidated Financial Results of which we are the independent auditors regarding, among other matters, the planned scope and timing of the audit and significant audit findings including any significant deficiencies in internal control that we identify during our audit.

(b) Review of the Consolidated Financial Results for the quarter ended March 31, 2026

We conducted our review of the Consolidated Financial Results for the quarter ended March 31, 2026 in accordance with the Standard on Review Engagements (SRE) 2410 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity', issued by the ICAI. A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with SAs specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

The Statement includes the results of the entities as listed under paragraph (a)(i) of Opinion and Conclusion section above.

We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, to the extent applicable.

Other Matters

a) The Statement includes the results for the quarter ended March 31, 2026 being the balancing figure between audited figures in respect of the full financial year and the published year to date figures up to the third quarter of the current financial year which were subject to limited review by us. Our report is not modified in respect of this matter.

b) We did not audit the financial statements of 1 subsidiary included in the consolidated financial results, whose financial statements reflect total assets of Rs. 5.16 Lakhs as at March 31, 2026 and total revenues of Rs Nil and Rs. Nil for the quarter and year ended March 31, 2026 respectively, total net (loss) after tax of Rs 1.38 Lakhs and Rs. 1.38 Lakhs for the quarter and year ended March 31, 2026 respectively and other comprehensive loss of Rs 1.38 Lakhs and Rs. 1.38 Lakhs for the quarter and year ended March 31, 2026 respectively and net cash flows of Rs. 5 Lakhs for the year ended March 31, 2026, as considered in the Statement. These financial statements have been audited/ reviewed, as applicable, by other auditors whose reports have been furnished to us by the Management and our opinion and conclusion on the Statement, in so far as it relates to the amounts and disclosures included in respect of these subsidiaries, is based solely on the reports of the other auditors and the procedures performed by us as stated under Auditor's Responsibilities section above.

Our report on the Statement is not modified in respect of the above matters with respect to our reliance on the work done and the reports of the other auditors.

For Deloitte Haskins & Sells LLP
Chartered Accountants
(Firm's Registration No. 117366W/W-100018)

P Usha
Parvathy
Digitally signed
by P Usha
Parvathy
Date: 2026.05.13
18:20:10 +05'30'
P Usha Parvathy
Partner
Membership No. 207704
UDIN: 26207704TRPQHO7867

Place: Chennai
Date: 13 May 2026

| Chemfab Alkalis Limited
CIN:L24290TN2009PLC071563
Regd. Office: Team House, Vandalur, Chennai 600 048.
Phone No: +91 44 66799595 Fax No: +91 44 66799561 | | | | | | |
| --- | --- | --- | --- | --- | --- | --- |
| (Amount Rs. In Lakhs) | | | | | | |
| STATEMENT OF CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED 31/03/2026 | | | | | | |
| Sl. No. | Particulars | 3 Months ended
31/03/2026
(Refer Note 7) | Preceding
3 Months ended
31/12/2025
(Unaudited) | Corresponding
3 months ended
31/03/2025 in the
previous year
(Refer Note 7) | Current Year
ended
31/03/2026
(Audited) | Previous year
ended
31/03/2025
(Audited) |
| 1 | Income
(a) Revenue from Operations
(b) Other Income
Total Income | 7,477.57
280.08
7,757.65 | 6,814.45
276.76
7,091.21 | 9,232.42
137.62
9,370.04 | 31,102.27
868.80
31,971.07 | 33,437.43
711.79
34,149.22 |
| 2 | Expenses
(a) Cost of Materials Consumed
(b) Purchase of Stock in trade
(c) Changes in Inventories of Finished goods and Work-in - Progress
(d) Direct Manufacturing Expenses - Power, Fuel & Others
(e) Employee Benefits Expense (Refer note 3)
(f) Finance Cost
(g) Depreciation and Amortisation Expense
(h) Other Expenses
Total Expenses | 1,997.83
268.40
14.32
2,910.32
632.32
214.24
795.05
802.67
7,635.15 | 2,138.98
-
140.35
2,706.43
659.01
203.48
746.59
975.70
7,570.54 | 2,784.34
-
115.92
3,120.00
613.50
156.56
1,060.70
1,265.08
9,116.10 | 9,501.89
268.40
526.82
11,230.55
2,632.17
768.69
2,841.95
4,220.60
31,991.07 | 10,212.04
735.23
(982.01)
11,880.23
2,550.52
492.50
3,633.13
4,669.35
33,190.99 |
| 3 | Profit/(Loss) before Exceptional Items (1-2) | 122.50 | (479.33) | 253.94 | (20.00) | 958.23 |
| 4 | Exceptional Items | - | - | 988.77 | - | 988.77 |
| 5 | Profit/(Loss) before Tax (3-4) | 122.50 | (479.33) | (734.83) | (20.00) | (30.54) |
| 6 | Tax Expense
- Current tax
- Deferred tax
Total Tax Expense | 35.62
38.42
74.04 | (18.20)
(16.34)
(34.54) | 102.25
81.55
183.80 | 194.12
128.53
322.65 | 378.10
285.39
663.49 |
| 7 | Net Profit/(Loss) after Tax (5-6) | 48.46 | (444.79) | (918.63) | (342.65) | (694.03) |
| 8 | Other Comprehensive Income
(a) Items that will not be reclassified to the Statement of Profit and Loss
- Remeasurement of net defined benefit liability
- Fair value gain on investments in equity instruments designated as at FVTOCI
- Income tax relating to items that will not be reclassified to profit or loss
(b) Items that will be reclassified to the Statement of Profit and Loss
Total Other Comprehensive Income/(Loss) Net of Tax | 42.64
(2.04)
(12.42)
-
28.18 | 14.52
(1.44)
(4.23)
-
8.85 | 40.95
(5.55)
(11.93)
-
23.47 | 86.21
(2.02)
(25.11)
-
59.08 | 58.09
(2.75)
(16.91)
-
38.43 |
| 9 | Total Comprehensive Income/(Loss) (7+8) | 76.64 | (435.94) | (895.16) | (283.57) | (655.60) |
| 10 | Profit/(Loss) for the year Attributable to:
Owners of the Company
Non-Controlling Interests | 48.46
-
- | (444.79)
-
- | (918.63)
-
- | (342.65)
-
- | (694.03)
-
- |
| 11 | Other Comprehensive Income/(Loss) for the year Attributable to:
Owners of the Company
Non-Controlling Interests | 28.18
-
- | 8.85
-
- | 23.47
-
- | 59.08
-
- | 38.43
-
- |
| 12 | Total Comprehensive Income/(Loss) for the year Attributable to:
Owners of the Company
Non-Controlling Interests | 76.64
-
- | (435.94)
-
- | (895.16)
-
- | (283.57)
-
- | (655.60)
-
- |
| 13 | Paid-up Equity Share Capital (Face Value of Rs. 10 per share)
(Refer Note 3) | 1,437.37 | 1,436.37 | 1,436.37 | 1,437.37 | 1,436.37 |
| 14 | Reserves (Other Equity) | | | | 36,103.32 | 36,562.44 |
| 15 | Earning per Share
(Face Value of Rs. 10 per share)
(a) Basic
(b) Diluted | (not annualised)
0.34
0.34 | (not annualised)
(3.09)
(3.09) | (not annualised)
(6.41)
(6.38) | (2.38)
(2.38) | (4.86)
(4.84) |

Chemfab Alkalis Limited CIN:L24290TN2009PLC071563 Regd. Office: Team House, Vandalur, Chennai 600 048. Phone No: +91 44 66799595 Fax No: +91 44 66799561
NOTES: 1 The Statement of Consolidated financial results comprises of the financial results of Chemfab Alkalis Limited (CAL) ("the Parent Company"), Chemfab Karalika Limited (CKKL) and Chemfab Hlitech Piping Limited (CHPL) ("the Subsidiaries") (together referred to as "the Group"). These financial results were reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Parent Company at their meeting held on 13 May 2026. 2 The Group has identified its reportable segments in accordance with Ind AS 108 - Operating Segments. Accordingly, two reportable segments i.e. Chemicals and Related Products and PVC - O Pipes have been identified, the details of which are given below: (Amount Rs. In Lakhs)
Sl. No.	Particulars	3 Months ended 31/03/2026	Preceding 3 Months ended 31/12/2025	Corresponding 3 months ended 31/03/2025 in the previous year	Current Year ended 31/03/2026	Previous year ended 31/03/2025
		(Refer Note 7)	(Unaudited)	(Refer Note 7)	(Audited)	(Audited)
I	Segment Revenue a) Chemicals and related Products b) PVC-O Pipes	6,168.19 1,311.24	5,380.87 1,464.95	6,078.96 3,153.46	21,814.51 9,346.75	20,292.38 13,145.05
	Less: Inter Segment Revenue	7,479.43 (1.86)	6,845.82 (31.37)	9,232.42 -	31,161.26 (58.99)	33,437.43 -
	Net Segment Revenue	7,477.57	6,814.45	9,232.42	31,102.27	33,437.43
	Segment Result before tax a) Chemicals and related Products b) PVC-O Pipes	143.74 (87.08)	(619.23) 66.62	(43.99) 316.87	(1,709.99) 1,589.88	(2,310.07) 3,049.01
II	Total Less: Inter Segment Result	56.66 -	(552.61) -	272.88 -	(120.11) -	738.94 -
	Less: Finance Cost	(214.24) 280.08	(203.48) 276.76	(156.56) 137.62	(768.69) 868.80	(492.50) 711.79
	Total Profit Before Tax	122.50	(479.33)	253.94	(20.00)	958.23
	Segment Assets: a) Chemicals and related Products b) PVC-O Pipes	31,989.11 21,906.91	33,019.12 21,120.32	31,617.08 15,858.21	31,989.11 21,906.91	31,617.08 15,858.21
III	Total Segment Assets Add: Unallocable assets	53,896.02 3,777.37	54,139.44 2,776.25	47,475.29 4,706.96	53,896.02 3,777.37	47,475.29 4,706.96
	Total Assets	57,673.39	56,915.69	52,182.25	57,673.39	52,182.25
IV	Segment Liabilities: a) Chemicals and related Products b) PVC-O Pipes	5,453.32 2,194.70	6,232.34 1,208.69	3,546.82 2,181.34	5,453.32 2,194.70	3,546.82 2,181.34
	Total Segment Liabilities	7,648.02 12,484.68	7,441.03 12,003.47	5,728.16 8,455.28	7,648.02 12,484.68	5,728.16 8,455.28
	Total Liabilities	20,132.70	19,444.50	14,183.44	20,132.70	14,183.44
	3 During the current year ended 31 March 2026, the Parent Company had allotted 10,000 Equity shares of Rs. 10 each upon exercise of Employee stock options by the eligible employees under Employee's Stock Option Scheme "CAESOS 2020". 4 The Group has estimated and recognized the impact of implementation of the New Labour Codes under Employee benefits expense for the year ended 31 March 2026. The impact of the same is not material to the results for the year. The Group continues to monitor the issuance and finalisation of State Rules and further clarifications from the Government in respect of other aspects of the Labour Codes. Any additional impact arising from such developments will be assessed and appropriately accounted for in the Consolidated Financial Results as and when such rules are notified or clarifications are issued. 5 The Statement of Consolidated Assets and Liabilities as at 31 March 2026 and the Statement of Consolidated Cash Flows are provided as annexures to this Statement. 6 The Board of Directors of the Parent Company has recommended a final dividend of 12.50 % (Rs. 1.25 per Equity Share of Rs. 10 each) which is subject to the approval of the shareholders in the forthcoming Annual General Meeting of the Parent Company. 7 The figures for the quarter ended 31 March 2026 and 31 March 2025 are the balancing figures between audited figures of the full financial year ended 31 March 2026 and published year to date figure upto third quarter ended 31 December 2025 and audited figures of the full financial year ended 31 March 2025 and published year to date figures upto third quarter ended 31 December 2024 respectively.

For Chemfab Alkalis Limited
Suresh Krishnamurthi Rao
Chairman
DIN No: 00127809

CCAL CHEMFAB ALKALIS LIMITED

BSE Limited
Corporate Relationship Department
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai- 400 001.
BSE – Scrip Code: 541269

National Stock Exchange of India Limited
The Manager, Listing Department
“Exchange Plaza”
Bandra - Kurla Complex, Bandra (E)
Mumbai - 400 051
NSE Symbol: CHEMFAB

Sub: SEBI Circular SEBI/HO/DDHS/P/CIR2021/613 dated August 10, 2021 as amended from time- Fund raising by issuance of debt securities by Large Entities

With reference to the subject cited above, Pursuant to SEBI Circular No. SEBI/HO/DDHS/DDHS-RACPOD1/P/CIR/2023/172 dated 19 October 2023, regarding the submission of Initial Disclosure and Annual Disclosure / Confirmation within the prescribed due date, by listed entities that were not identified as large corporates, are required to submit confirmation of non-applicability of the said Circular to the Exchange in the specified mode.

In accordance to above, we would like to inform you that our company Chemfab Alkalis Limited, is "Not a Large Corporate" as per the applicability criteria given under Chapter XII of SEBI Operational Circular dated August 10, 2021 as amended from time to time.

ANAB
CENTRE FOR ANABASI
CERTIFICATION
No. 13410-80220 / 2005/71566
No OHSAS 18001 and ISO 14001 Certified Company

CIN No.: L24290TN2009PLC071563
Member - Dr. Rao's Group of Companies
Regd. Off: 'TEAM House', GST Road, Vandalur, Chennai - 600 048, India.
Plant: 'Gnanananda Plaza', Kalapet, Puducherry - 605 014, India Ph: +91 413 2655111,
E-mail: [email protected], www.chemfabalkalis.com

CCAL

The details as required under aforesaid circular is stated below:

Name of the company	Chemfab Alkalis Limited
CIN	L24290TN2009PLC071563
Outstanding borrowing of company as on 31 March 2026 (in Rs. Lakhs)	Rs. 8143 Lakhs
Highest credit rating during the previous FY along with name of the CRA {Size of issue (in Lakhs)}	Bank Loan Facilities	Bank Loan Facilities
	Rs. 270 Lakhs	Rs. 16730 Lakhs
	IND BBB+/Negative/IND/A2	IND BBB+/Negative/IND/A2
Name of stock exchange* in which the fine shall be paid, in case of shortfall in the required borrowing under the framework	Not Applicable

Digitally signed by
BHARATRA
J PANCHAL
Date: 2024.03.13
20:09:13 +00'00'

Bharatraj Panchal
Company Secretary
FCS: 9828

Certificate No. 0142-80238 / 290571566
All GPLKD / BZC and ISO 14001 Certified Company

CIN No.: L24290TN2009PLC071563
Member - Dr. Rao's Group of Companies
Regd. Off: 'TEAM House', GST Road, Vandalur, Chennai - 600 048, India.
Plant: "Gharananda Place", Kalapat, Puducherry - 605 014, India Ph: +91 413 2655111,
E-mail: [email protected], www.chemfabalkalis.com

AI assistant

Chemfab Alkalis Ltd Audit Report / Information 2026

62225_rns_2026-05-13_9ac19b21-17fd-4e8e-86a8-9d2fcbfba7e7.pdf

Sub: Outcome of the Board Meeting

CHEMFAB ALKALIS LIMITED

Annexure-1

Details of the Auditors

INDEPENDENT AUDITOR'S REPORT ON AUDIT OF ANNUAL STANDALONE FINANCIAL RESULTS AND REVIEW OF QUARTERLY FINANCIAL RESULTS

TO THE BOARD OF DIRECTORS OF CHEMFAB ALKALIS LIMITED

Opinion and Conclusion

(a) Opinion on Annual Standalone Financial Results

(b) Conclusion on Unaudited Standalone Financial Results for the quarter ended March 31, 2026

Deloitte Haskins & Sells LLP

Management's and Board of Directors' Responsibilities for the Statement

Auditor's Responsibilities

(a) Audit of the Standalone Financial Results for the year ended March 31, 2026

Deloitte Haskins & Sells LLP

Other Matters

Chemfab Alkalis Limited

NOTES:

(Amount Rs. In Lakhs)

INDEPENDENT AUDITOR'S REPORT ON AUDIT OF ANNUAL CONSOLIDATED FINANCIAL RESULTS AND REVIEW OF QUARTERLY FINANCIAL RESULTS

TO THE BOARD OF DIRECTORS OF CHEMFAB ALKALIS LIMITED

Opinion and Conclusion

(a) Opinion on Annual Consolidated Financial Results

(b) Conclusion on Unaudited Consolidated Financial Results for the quarter ended March 31, 2026

Management's and Board of Directors' Responsibilities for the Statement

Auditor's Responsibilities

(a) Audit of the Consolidated Financial Results for the year ended March 31, 2026

(b) Review of the Consolidated Financial Results for the quarter ended March 31, 2026

Other Matters

AI assistant

Chemfab Alkalis Ltd — Audit Report / Information 2026

62225_rns_2026-05-13_9ac19b21-17fd-4e8e-86a8-9d2fcbfba7e7.pdf

Sub: Outcome of the Board Meeting

CHEMFAB ALKALIS LIMITED

Annexure-1

Details of the Auditors

INDEPENDENT AUDITOR'S REPORT ON AUDIT OF ANNUAL STANDALONE FINANCIAL RESULTS AND REVIEW OF QUARTERLY FINANCIAL RESULTS

TO THE BOARD OF DIRECTORS OF CHEMFAB ALKALIS LIMITED

Opinion and Conclusion

(a) Opinion on Annual Standalone Financial Results

(b) Conclusion on Unaudited Standalone Financial Results for the quarter ended March 31, 2026

Deloitte Haskins & Sells LLP

Management's and Board of Directors' Responsibilities for the Statement

Auditor's Responsibilities

(a) Audit of the Standalone Financial Results for the year ended March 31, 2026

Deloitte Haskins & Sells LLP

Other Matters

Chemfab Alkalis Limited

NOTES:

(Amount Rs. In Lakhs)

INDEPENDENT AUDITOR'S REPORT ON AUDIT OF ANNUAL CONSOLIDATED FINANCIAL RESULTS AND REVIEW OF QUARTERLY FINANCIAL RESULTS

TO THE BOARD OF DIRECTORS OF CHEMFAB ALKALIS LIMITED

Opinion and Conclusion

(a) Opinion on Annual Consolidated Financial Results

(b) Conclusion on Unaudited Consolidated Financial Results for the quarter ended March 31, 2026

Management's and Board of Directors' Responsibilities for the Statement

Auditor's Responsibilities

(a) Audit of the Consolidated Financial Results for the year ended March 31, 2026

(b) Review of the Consolidated Financial Results for the quarter ended March 31, 2026

Other Matters

More from Chemfab Alkalis Ltd

Chemfab Alkalis Ltd Audit Report / Information 2026